Release date: 2016-07-01 According to the World Health Organization and the United Nations Department of Health (China Women's Health Survey Report), the incidence of gynecological diseases among women of childbearing age in China is over 70%, and more than 5% of women have affected normal work due to serious illness. Life, especially the disease of "infertility", has made countless families dark. According to the survey released by the China Population Association, there are currently more than 40 million infertile patients in China, accounting for 12.5% ​​of the childbearing population. This is a data that has to be alarmed. Infertility has risen to a national problem. How to check and prevent such diseases has become a common concern in today's society. Source: Medical Device Network The United States Food and Drug Administration (FDA) has published the Dietary Supplement Health and Education Act (DSHEA), which provides for dietary supplements. A product (other than tobacco) intended to supplement the diet may contain one or more of the following dietary ingredients: A vitamin, a mineral, an herb (herbal) or other plant, an amino acid, a food component used to increase the total daily intake to supplement the diet, or a concentrate, metabolite, component, extract or combination of the above ingredients, etc. It also includes approved new drugs, vitamins or biologics that have been marketed as dietary supplements or food products before they are approved, issued or licensed. The DSHEA defines dietary supplements as their composition and labeling requirements: the product form may be pill, capsule, tablet or liquid; The product shall not be used as a substitute for ordinary foods or as an exclusive dietary item. The product shall be labeled as a "dietary supplement". Dietary Supplements,Arachidonic Acid Powder,Kava Root Powder,Kava Root Extract Powder Xi'an Double H Health Technology Co., Ltd , https://www.xahnhcj.com
Clinical application of dynamic DR in gynecological examination
There are many factors leading to female infertility, which are roughly summarized as the diseases caused by these aspects : 1. Female genital malformation; 2. Uterine salpingitis; 3. Other factors. At present, hysterosalpingography (HSG) is a recommended method for female genital malformation and hysterosalpingitis. With the emergence of visual dynamic DR, the level of gynecological angiography is further improved. Dynamic DR relies on advanced features such as large format, visualized spotting, and high-definition and real-time playback. It can be applied to a variety of infertility and other gynecological examinations.
(1) Congenital malformation of female genital tract
The incidence of congenital malformations in female genital tract is 0.1% to 0.5%, and it accounts for about 9% of infertile or aborted women, often with congenital malformations of the kidney. The fallopian tube, uterus, cervix and vaginal upper 1/3 and vaginal 1/3 are from both sides of the Müllerian tube and sinus-vaginal ball, which are fused and cavityd during development, while the lower third of the vagina develops separately. Therefore, abnormalities in the development, fusion, and re-cavity of Müllerian tubes can cause various types of malformations in the female reproductive tract. More common are different types of uterus malformations, including single-horned uterus, double uterus, double-horned uterus, and mediastinal uterus. Uterine malformations can lead to infertility, miscarriage and premature birth, and the type of congenital malformation of the uterus is important for the selection of appropriate treatments.
Dynamic DR imaging: single uterus
Imaging findings: In the application of dynamic DR routine hysterosalpingography, the uterine cavity can be clearly displayed, and most uterine malformations can be diagnosed according to the shape of the developing lumen and the presence or absence of mediastinum and its length. In this case, The development of the horned uterus is outstanding.
(two) uterine salpingitis check
Uterine salpingitis is one of the main causes of infertility in women. Infertility due to fallopian tube disease accounts for 20% to 50% of infertility. Uterine salpingitis can be divided into non-specific and tuberculous. Among them, specific salpingitis is generally called uterine salpingitis. Acute stage of uterine salpingitis shows hyperthermia, lower abdominal pain, vaginal discharge or multiple uterine bleeding. The chronic phase is mainly low back pain, bulging sensation and menstrual disorders. Tuberculosis generally has no specific signs or conventional general infections, with infertility. At present, domestic and foreign medical institutions using hysterosalpingography under dynamic DR are the main methods for examining uterine salpingitis, and there is also a therapeutic effect of separating adhesions.
1, chronic salpingitis:
Dynamic DR imaging: bilateral fallopian tubes are not smooth
Imaging findings: the lesions were mostly bilateral, showing that the tubal thickness was uneven, but still weak; the left fallopian tube showed incomplete obstruction, the ampulla appeared slightly dilated, and the overall uterine cavity was poorly developed. Initial diagnosis: tubal distortion, combined with the patient's medical history, to determine the presence of chronic fallopian tube inflammation.
2, tubal tuberculosis:
Imaging findings: Under dynamic DR imaging, the uterine cavity is irregular and the uterine cavity is relatively narrow and deformed. The bilateral fallopian tubes are narrow, thin, and irregularly edged. The initial diagnosis of this case was: bilateral tubal tuberculosis and hydrops on the right side of the fallopian tube.
Through the analysis of some common cases of gynecological diagnosis of dynamic DR above, I am reminded of a topic that has been discussed frequently in the industry in recent years. In the context of the DR industry where competition is so fierce and product homogeneity is so serious, why is “dynamic DR†a sudden emergence? Become the focus of the industry, the darling of the industry? I think the root cause is the product design concept of dynamic DR "precise diagnosis" and the constant pursuit of the benefits brought by technological innovation to patients. This is not only the end point, with the continuous breakthrough of dynamic technology, the country's further support, I believe that more and more diseases will benefit from the accurate diagnosis of dynamic DR in the future.